NCT04730063

Brief Summary

This is a prospective, observational study to assess agreement of pulmonary health parameters measured by a new non-invasive physiologic monitor, the VQm pulmonary health monitor (PHM)™ with clinical gold standards.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 29, 2021

Completed
19 days until next milestone

Study Start

First participant enrolled

February 17, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

1.9 years

First QC Date

January 25, 2021

Last Update Submit

April 25, 2022

Conditions

Keywords

Physiologic MonitorsAcute Care Medicine

Outcome Measures

Primary Outcomes (1)

  • Comparison of pulmonary function parameters to known clinical standards

    Assess agreement between measurements from VQm PHM™ to clinical gold standards

    Through study completion, an average of 12 months

Interventions

Procedure: Non-invasive measurements obtained with the VQm PHM™

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective surgery requiring mechanical ventilation

You may qualify if:

  • Age greater than 18 years
  • Scheduled for an elective surgical procedure with an anticipated duration of more than 2 hours requiring general anesthesia without the use of inhalation anesthetics
  • Surgical procedure that requires pressure-controlled positive pressure ventilation using an endotracheal tube
  • Surgical procedure that requires the use of intra-arterial pressure monitoring and/or a Swan-Ganz catheter for the monitoring of continuous cardiac output

You may not qualify if:

  • Patients who require ventilation tidal volumes less than 250cc
  • Age less than 18 years
  • Pregnancy
  • Prisoners
  • Surgical procedure which requires carbon dioxide (CO2) insufflation
  • Unable to tolerate a transient increase in inhaled CO2
  • Unable to tolerate a transient increase in inhaled nitrous oxide (N2O) or use of N2O is contraindicated
  • Patients who require a high fraction of inspired oxygen (FiO2) (\>70%) to maintain a hemoglobin saturation (SpO2\>98%)
  • Women, minorities or non-English speaking subjects will not be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC Davis Medical Center

Sacramento, California, 95817, United States

RECRUITING

Study Officials

  • Neal W Fleming, M.D., Ph.D.

    Director, Cardiovascular and Thoracic Anesthesiology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Neal W Fleming, M.D., Ph.D.

CONTACT

Nathan Ayoubi, BSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2021

First Posted

January 29, 2021

Study Start

February 17, 2021

Primary Completion

January 1, 2023

Study Completion

February 1, 2023

Last Updated

April 27, 2022

Record last verified: 2022-04

Locations